$15.03
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
Overview
52-week range
$8.27
$30
31% of range
Avg surprise (last 3)
-22.0%
Avg reaction (last 2)
+0.3%
50% positive
Latest IV / EM
104%
EM ±23.8% · $15 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.32 | $-0.28 | -14.3% | -45.5% | -3.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.21 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.21 | $-0.20 | -5.0% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.22 | $-0.15 | -46.7% | — | +4.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.18 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.16 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.16 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.20 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.29 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.27 | -$0.21 | -28.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | — | $9M | $9M | $8M | — | $8M | $8M |
| Cost of revenue | $4M | — | $3M | $4M | $3M | — | $3M | $3M |
| Gross profit | $8M | — | $6M | $6M | $5M | — | $5M | $5M |
| Operating income | $-8M | — | $-5M | $-6M | $-6M | — | $-5M | $-5M |
| Net income | $-10M | — | $-6M | $-6M | $-6M | — | $-5M | $-4M |
| EPS (diluted) | $-0.32 | — | $-0.21 | $-0.21 | $-0.22 | — | $-0.18 | $-0.16 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $36M | $46M | $38M | $42M | $12M | $20M | $22M | $33M |
| Inventory | $9M | $8M | $7M | $6M | $7M | $7M | $7M | $8M |
| Total current assets | $55M | $64M | $51M | $54M | $24M | $33M | $34M | $47M |
| Total assets | $93M | $98M | $60M | $63M | $30M | $39M | $40M | $53M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $75M | $70M | $44M | $43M | $10M | $14M | $11M | $20M |
| Total equity | $19M | $28M | $16M | $20M | $20M | $25M | $29M | $32M |